NURS FPX 8024 Assessment 1 Nongovernmental Agencies Involved in Global Issues

Student name

Capella University

NURS-FPX8024

Professor Name

Submission Date

Nongovernmental Agencies Involved in Global Issues

Program for appropriate technology in health (PATH) is a nonprofit organization that promotes equity in health globally with innovative solutions to technology. PATH was established in 1977 and it works in 70+ countries, which creates evidence-based health interventions to underserved populations (PATH, 2024a). The organization deals with key healthcare inequalities by developing scalable technologies and enhancing health systems in low-resource environments. The multisectoral approach of the PATH is an integration of research and product development and implementation in order to address the issue of infectious disease, maternal mortality, and access to vaccines.

Section I

About the Non-Governmental Funding Organization

Program for appropriate technology in health (PATH) is a renowned non profit making organization that promotes health equity across the globe by developing technological solutions. The organization was founded in 1977 in Seattle, Washington and originally its specialization was adaptation of contraceptive technologies and family planning (PATH, 2024a). The founding members had the vision of establishing sustainable health technologies that were specifically meant to be used in low-resource environments and under-served communities across the world. The PATH is presently operating in 70+ countries and is creating evidence-based interventions to address the issues of infectious diseases, maternal health, and access to vaccines (PATH, 2021). The research has shown that non-governmental organizations (NGOs) that have a high concentration on technology have a higher potential to be scaled than their counterparts, who are focused on the traditional delivery of services when it comes to the reduction of the disparity in health (Mota et al., 2025). It has around 1,600 professionals spread across the world in the form of researchers, program managers, field coordinators, and health technology experts (PATH, 2024b). PATH has diversified sources of funding such as government contracts and foundation grants which enhance its mission without compromising programmatic independence and innovation ability.

Mission and Goals

The PATH mission statement aims at ensuring that the world becomes a better place with better health through progressive partnerships and innovation of technologies to assist the underprivileged groups found around the world. The charter underpinning of the organization is aimed at the design of the pertinent health technologies that address some of the concerns in the healthcare low-resource settings (PATH, 2024c). The PATH has some strategic objectives which include; to develop scalable health innovations, to empower health systems and to improve the maternal and child health outcomes of the world. The organization in particular is targeted at developing vaccines, diagnostic instruments, reproductive health technologies and nutrition interventions among vulnerable populations. The PATH mission demonstrates that it is in line with the global health priorities because evidence-based research is utilized and sustainable technology solutions are being applied. The measurable goals of the organization include the number of lives saved, the rate of disease prevention, and the increase in the capacity of the health system (Lal et al., 2020). The measures of the program effectiveness are the acceptance of technology, the success of the clinical trials, and the improvement of health at the level of the population of target areas.

Transparency and Accountability

The PATH ensures high transparency through detailed annual reports, which justifies money expenditure and programmatic performance in all the countries of operation. The company has left detailed reports on revenue analysis that shows diversified sources of revenue, including government contracts (60) and foundation grants (25), which have been consistent in operation (PATH, 2024d). The PATH governance system is a Board of Directors which is represented internationally and the governance has stringent accountability measures. The company being analyzed had enhanced equity and inclusion policies following internal audits that revealed that there were certain areas of organizational paired culture that were available. Research has demonstrated that financial disclosure and good Governance frameworks have immense positive effects on negotiating the accountability and success of the programs in the global health institutions (Chang et al., 2021). The decision making processes are defined by representative consultations between the international heads of countries, offices and the implemented programs of the country all over the world. Independent audits and GuideStar certification on a cyclic basis indicate that PATH is following the requirements of financial custodianship and transparency with respect to the activities of the organization. 

Program Effectiveness

The PATH has proven excellent program performance by its innovative development of health technology to address key disease burdens in resource-constrained environments across the world. The MenAfriVac program of the organization eradicated the cases of meningitis A in six months in the areas of vaccination, securing 100 million people (PATH, 2023a). The PATH malaria programs were able to result in the reduction of child mortality rates by 50% due to the distribution of insecticide-treated bednets and the implementation of diagnostic tools. The adaptive capacity of the organization is reflected in quick protocols of the vaccine development, as in the case of meningitis vaccine creation, the organization has not only created the vaccine in five-year periods not before but has also set records. The PATH constantly tests intervention methods based on the employment of rigorous clinical trials and population outcome tests through collaborative research relationships. The reproductive health initiatives tackle the barriers to accessing contraceptives by using new technologies such as the SILCS diaphragms and Women Condoms technologies (Beksinska et al., 2020). The measurement of program impact uses the total metrics such as vaccine efficacy rates, technology adoption measures, and health system strengthening measures in the areas of operation.

Partnership and Collaboration

The PATH also forms strong collaborative relationships with the multilateral organizations to increase capacity to develop and implement health technologies during the global operations. The organization is also involved in many partnerships with the World Health Organization in vaccine development programs, such as the revolutionary MenAfriVac project that aims at sub-Saharan Africa (PATH, 2023b). The PATH collaborates with the national health ministries in the countries of operation to incorporate the innovative technologies in the current health care delivery systems. The organization has strategic partnerships with pharmaceutical firms such as GlaxoSmithKline and Sanofi in the research and drug development programmes. The PATH works with the academic institutions, such as Harvard Medical School and the University of Washington to conduct research capacity building studies and evaluation studies (PATH, 2023c). The partnership networks make PATH to tap into specialized technical expertise, obtain diversified sources of funds and have scalable impact. The collaborative models enable transfer of technology processes, regulatory approval channels, and sustainable programs implementation among target groups.

Financial Management

The PATH shows excellent financial stewardship by following strict budgetary control and ensuring strategic allocation of resources in 70 plus countries of operation in the world. The organization attains impressive diversification in funding with government contracts constituting 60 percent and foundation grants forming 25 percent of the overall sources of revenue (PATH, 2024a). Its annual operating budget is as high as $303 million, which supplies innovative programs of health technology development and implementation and 1,600 specialized staff throughout the world (PATH, 2024b). PATH has high financial reserves, which make it easy to scale the program quickly and continue carrying out research in difficult conditions. The issue of financial sustainability is introduced by the stable rates of grant renewals, open stewardship approaches, and reported impact measures in global health innovation (Rid et al., 2024). The organization also spends money on programmatic activities, which is an outstanding standard of operation efficiency. Diversified funding portfolio eliminates the risk of dependency and provides stable funding of long-term health technology development programs.

Section II

Logistic

Name: Dr. Nanthalile Mugala, MD, MMed
Position: Chief of the Africa Region
Organization: PATH
Contact:info@path.org, +1-206-285-3500
Website: path.org
Organization Address: 2201 Westlake Avenue, Suite 200, Seattle, WA 98121, USA
Interview Date/Location: September 10, 2025, conducted via video conference

Q: How long have you been part of PATH?

I also work with PATH and have been employed there since the last twelve years as a pediatrician specializing in child health interventions in sub-Saharan Africa. My first placements were working on vaccine delivery schemes and maternal health programs in various African states. I have worked in the Africa Region as the Chief during the last three years and was in charge of strategic operations and the development of programs. My experience with PATH has helped me to promote health equity in underserved populations using innovative technology solutions.

Q: Can you describe a typical day and what you enjoy most about your work?

I begin my day by making strategic planning calls to country directors in every part of our operations in Africa discussing program implementation issues. I would do this by keeping track of the vaccine development progress, hold meetings with governments through the health ministries and adhere to the international health standards. The best part to me is when communities acquire lifesaving health technologies like MenAfriVac, which eliminates preventable diseases in the communities. The assurance of equity to health is observed through the observation of children being vaccinated against something novel, and mothers being given superior services concerning reproductive health.

Q: What challenges do you face, and how do you overcome the hurdles?

The rural environments have minimal medical facilities that can have adverse effects on the adoption of various technologies and sustainable programs needed to support the target zones. The steps associated with the process of approving the regulations vary significantly in the countries, which leads to the delay in the provision of proven health innovations to the populations at risk. We cope with the negative aspects that have the long-term ties with the government, the development of the local skills, and the adaptation of technologies to the cultures accordingly.

Q: How did you start in humanitarian medicine?

During my pediatric training experience in Zambia, avoidable disease was identified as the cause of childhood deaths due to untreatable diseases in other regions of the world. Seeing health disparities and technology gaps was one of the experiences that motivated me to change to the underserved population in international health innovation. The PATH mission to develop the appropriate technologies and to transform health systems to be far stronger perfectly aligned with my personal professional agenda.

Q: What aspects of your job are most fulfilling to you?

The most impactful are those cases when new health technologies result in a change of health of target populations on a population level. One of the sustainable effects of the implementation of MenAfriVac in 26 African countries has been witnessed by the eradication of such a disease as meningitis A observed through the empowerment of the local health staff with new technologies. This will ensure continuity in change following the time of direct intervention of PATH. Systemic solutions involve formation of partnerships with governments, which affect the populations in the long-run at a large scale.

Mission, Activities, and Community Impact

Mission and Goal

What is the organization’s mission and primary goals?

The mission of the PATH is to promote health equity by developing innovative technologies and collaborating strategically with communities that are underserved all over the world. The core aims of the organization are to develop relevant health technologies, enhance health systems, and maternal and child health outcomes. The organization will strive to eradicate preventable diseases with evidence-based interventions and promote sustainable health development in the world. Our priorities focus on the scalable innovation development, strict research implementation, and capacity building of vulnerable population that needs accessible healthcare solutions.

How do policies affecting healthcare and population health outcomes affect your agency?

The process of regulatory approval of various countries has a serious impact on our program implementation plans and technology deployment time frames. The policies of international funding and the priorities of donors directly determine our areas of research and opportunities to expand operations capacity. The policies of the national health system predetermine our systems of collaboration with government ministries and the possibility of integration of innovative technologies into them. The trade laws and the intellectual property laws impact on the capability to effectively transfer health technologies to the target populations.

Programs and Services:

Can you describe the key programs and services the organization provides?

The PATH invents new health technology, such as vaccines, diagnostic technology, reproductive health technology, and nutrition interventions in resource-restricted environments. We have specialized services which include vaccine development programs, malaria prevention programs, maternal health technology solutions, and health system strengthening programs. We also offer technical support to transfer technology, capacity building training and generation of evidence by conducting stringent clinical trials. Research and development skills consist of product innovation, implementation science research, and policy advocacy in line with adoption of health technology.

How do the programs address the specific needs of the community?

Our technology strategies focus on the common health problems that are presented in the community needs assessment and epidemiological data analysis. The programs bring in the local cultural settings, and resources limitation without compromising on scientific rigor and the international quality standards. The high-burden diseases that are targeted by our interventions are those that impact women, children, and marginalized groups that lack access to healthcare. Community participation makes technologies to be affordable, acceptable, and sustainable in the current health systems infrastructures.

Who is your target population?

The PATH targets underserved groups in low-and middle-income nations that do not have access to the necessary health technologies and quality healthcare services. The main beneficiaries are women of child bearing age, infants, and children, and those communities that are infected with infectious diseases and malnutrition. Our demographics will include rural areas, underserved groups, and nations where health infrastructure in the health system is weak and thus needs innovative solutions. The organization targets the groups facing health inequities because of geographic isolation, poverty, or poor service provision to the health.

Community Engagement:

How does the organization engage with the community?

The PATH focuses on stakeholder consultation and cultural fit in the introduction of health technologies in various operational environments in the world. We collaborate with community leaders and traditional healers, as well as the local health workers to make sure that technology will be accepted and implemented properly. Health literacy programs inform the populations on how to prevent disease, the benefits of technology and how to use them by using culturally sensitive methods. Feedback mechanisms allow the program to be improved continuously as well as the incorporation of the preferences of the community and the local concerns regarding health innovations.

Are there specific outreach or involvement strategies in place?

The PATH has community health workers who make household visits and demonstrate technology and educate using native languages. Research teams use mobile clinics and field studies to involve rural populations in research to know about technology requirements and obstacles. The communication strategies are based on local media, meetings with the communities, and visual materials translated into regional languages and educational backgrounds. Community advisory boards are involved in giving recommendations in the designing and implementation of the program and making certain that health technology introduction is culturally sensitive.

Impact Assessment:

How does the organization measure the impact of the programs?

The PATH uses stringent measures of evaluation such as adoption rates of the technology, health outcomes, and cost-effectiveness analysis of the program sites. Randomized controlled trials and implementation science studies are the research methods that our research teams use to evaluate the effectiveness and scalability of interventions. Other programs like monitoring systems are used to monitor patterns of technology utilization, user satisfaction, and health system integration to have a comprehensive program evaluation. Impact measurements are validated through independent assessments by academic partners and also optimization opportunities are identified in the deployment strategies of the technology.

Can you provide examples of success stories or positive outcomes from your initiatives?

Under the MenAfriVac program, in six months time, there was no transmission of meningitis A that had put more than 100 million people at risk in sub-Saharan Africa. Our Ultra Rice project decreased prevalence of anemia among Cambodian children by 40% using micronutrient fortification programs. Vaccine-vial monitor technology not only stopped waste of the vaccines but also enhanced the quality of immunization in the resource constrained environment across the globe. The careHPV test allowed screening of the cervical cancer in clinics that were not connected to electricity, thus accessing the hitherto underserved women groups.

Collaborations and Partnerships:

Does the organization collaborate with other non-profits, government agencies, or businesses?

The PATH has strategic partnerships with the WHO in vaccine development programs and health policy advocacy. Collaborations with the national health ministry’s help in integrating the technology into the existing health systems and regulatory approvals. We also work with pharmaceutical companies, such as GlaxoSmithKline and the Sanofi on scale-up activities of vaccine research and manufacturing. Research capacity building and generation of evidence of health technology innovations are academic partnerships with universities.

How do the partnerships enhance the organization’s ability to serve the community?

Collaborative networks enhance the technical capacity of PATH as well as tapping into the expertise of various organizational partners and stakeholders. The government partnership guarantees the compliance with the regulations and sustainable integration of technologies into the national health programs. Collaborations in the industry allow the scale-up of manufacturing and accessing the market of proven health innovations in the target countries. Multi-sectoral coordination eliminates duplication of resources, but provides full transfer of technology transfer and implementation.

Volunteer and Staff Involvement:

How are volunteers involved in the organization’s activities?

The PATH has competent professionals who are consultants and members of the advisory boards, who bring expert knowledge to the technology development projects. Volunteer researchers are engaged in field research and data gathering in the process of experiencing global health innovation. Student interns facilitate research programs, program assessment, and knowledge transfer programs in both headquarters and field offices. Technology demonstrations and health education activities in active countries are helped by community volunteers.

Can you share insights into the dedication and expertise of the staff?

The PATH has some of the leading scientists, engineers, experts in public health, and program managers who have a wide experience in global health around the world. The staff are exceptional as they offer fieldwork in harsh conditions to promote health equity among the underserved groups. The continuous professional development programs ensure the competency of staff in new technology and implementation science methods across careers. Local personnel bring in invaluable cultural information and local ties that are keys to a successful adoption of technologies and the sustainability of the program.

Challenges and Adaptability:

What challenges has the organization faced, and how has the system overcome the problems?

Delays in regulation in various countries tend to delay the timeline of technology implementation and restrict access to life-saving health technologies. The presence of limited healthcare infrastructure in target areas limits the potential of implementing technology and maintaining a program in the long run. The PATH deals with the barriers by developing government partnerships, local capacity building projects, and technology adoptions plans. The barriers of intellectual property and manufacturing demands inventive financial tools and substitution of the production route.

How does the organization adapt strategies based on changing community needs?

The PATH also undertakes periodic needs analyses and epidemiological surveys in order to define emerging health priorities and technology needs. Teams that are involved in implementation alter the technology designs according to the feedback of the users and the field performance data of the operational sites. The strategies of the program change with the changes in the disease burden and the priorities in strengthening the health systems of target countries. The process of community engagement is used to refine the technology without compromising the scientific validity and cost-effectiveness standards.

Describe an unmet health issue that your organization has identified.

Maintenance of cold chain of vaccines in remote territories is not properly considered, which restricts the coverage of immunization of vulnerable groups. The diagnostic technologies of the neglected tropical diseases do not have affordable point of care technologies applicable in resource limited health care units. The designs of reproductive health technologies should be better in conservatism societies to meet cultural and user interests. Digitization of the health system should have the right technologies to facilitate the management of data and tracking of patients in low-connectivity situations.

Financial Sustainability:

How does the organization secure funding for the programs?

The PATH has diversified sources of revenue, such as government contracts, foundation grants and bilateral donor agreements to sustain its operations. The pharmaceutical companies are in strategic partnerships whereby they can offer co-funding opportunities to the vaccine development and the technology commercialization programmes. The applications to grants are directed at large foundations that fund the activities of global health innovation and health system strengthening in the world. Emergency funding appeals help to mobilize funds to deploy rapid technology in case of a health crisis that needs immediate intervention.

Can you provide information on financial transparency and stewardship?

To ensure accountability of stakeholders, the PATH releases detailed annual reports covering sources of revenue, spending patterns and program impact measures. Annual financial reviews are conducted by independent auditing firms and they make sure that the international accounting standards and donor requirements are met. The organization has a low administrative cost with 86.4 percent of resources going to direct program implementation and technology development. The financial oversight committees are in charge of fund management in a responsible manner and they are also transparent in the budget allocation and the strategic decision making process.

Future Plan

What are the organization’s future plans and initiatives?

The PATH will increase vaccine development capacities on neglected diseases in underserved populations in resource-constrained settings. The company expects to enhance digital health technologies to enable telemedicine and health data management in remote locations. The future plans involve increasing the capacity of local production of health technologies as well as the construction sustainable supply chains. The research will be directed toward the areas of antimicrobial resistance solutions and new diagnostic methods of the emerging health threats.

How does the vision portray evolving to better serve the community?

The PATH will contribute to the investment in the local workforce development, which will ensure the possibility of transferring technology. The advocacy campaigns to facilitate change of policy to favor health technologies to be easily accessible and affordable will increase in the organization. The pillar of climate resilience will also be integrated in future programming besides improving preventive health technology portfolios. Technology platforms will involve artificial intelligence and machine learning to improve health service delivery and population health outcomes.

Reflection

The Dr. Mugala interview showed that PATH embraces evidence-based innovation and development of sustainable health technology in the world. She has observed that superior global health interventions should possess deep communal engagement and culture suitability as far as the compatibility of technology is concerned. This development of partnership that has been put in place enables the organization to amplify the effect and create the local capability to maintain the organization in the long run. Research indicates that community-based technology design helps to achieve significantly improved adoption and health-related academic outcome in a considerably diverse range of cultures (Coleman et al., 2023). The discussion established that the prestigious institutions of health innovation must create a balance between rapid technology advancement and strict reviews and human approval. The systematic approach to the planning of healthcare facilities renders the PATH applicable in terms of health technologies being scientifically and culturally acceptable in the varied working environments.

Conclusion

The general analysis of PATH indicates that the organization contributes significantly to the health equality of the whole world in the context of innovation of technologies and strategic cooperations. The analysis revealed that PATH has been successful in controlling the extreme health disparity by evidence-based responses to the challenges by controlling the governing structures and ensuring financial management measures at the international level in 70+ countries. The informational interview with Dr. Nanthalile Mugala yielded productive information on the working strategies of PATH, community engagement and the responsiveness ability of the organization to the dynamic health needs on resource limited settings. The PATHs attempts to create the correct health technologies, the capacity building of the employees of the local communities are examples of the scenarios where the intervention of the nongovernmental organization can introduce the collaboration and the culturally oriented delivery of the necessary programs that can be long-term. The outcomes of the organization, including the focus on measurable outcomes, financial transparency, and sustainable transfer of technology, make PATH an excellent model of efficient delivery of global health interventions through the targeting of the underserved populations that require new ways of healthcare delivery.